Medicine and Dentistry
Cancer Cell
100%
Lipocortin 2
100%
Bladder Cancer
100%
Transitional Cell Carcinoma
100%
Neoplasm
66%
Messenger RNA
66%
Interleukin 6
33%
Overall Survival
33%
Biological Marker
33%
Cytokine
33%
Metastatic Carcinoma
33%
Secretion (Process)
33%
Gelatinase B
33%
Platelet Derived Growth Factor
33%
Downregulation
33%
The Cancer Genome Atlas
33%
Bladder Tissue
33%
Progression Free Survival
33%
Papilloma
33%
Disease Specific Survival
33%
Metastatic Bladder Cancer
33%
Tumor Histology
33%
Fibrinolysin
33%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Annexin A2
100%
Messenger RNA
66%
Downregulation
33%
Secretion (Process)
33%
Interleukin 6
33%
Overall Survival
33%
Plasmin
33%
Fibrinolysin
33%
Cytokine
33%
Platelet-Derived Growth Factor
33%
Gelatinase B
33%
MMP9
33%
Interleukin 8
33%
Disease Specific Survival
33%
Papillary Tumor
33%
Progression Free Survival
33%
ANGPT2
33%
Keyphrases
Annexin A2 (ANXA2)
100%
High-level Expression
100%
Upper Tract Urothelial Carcinoma
100%
Cell-derived
33%
Bladder Cancer Cells
33%
MRNA Expression
22%
Interleukin-6
11%
Therapeutic Target
11%
Interleukin-8
11%
Tumor
11%
Platelet-derived Growth factor-BB (PDGF-BB)
11%
Plasmin Generation
11%
Promising Biomarkers
11%
Proliferation Migration
11%
Matrix metalloproteinase-9 (MMP-9)
11%
Bladder Cancer
11%
Angiogenic Factors
11%
Angiogenic Cytokines
11%
Basic Fibroblast Growth Factor (bFGF)
11%
Bladder
11%
Pathology Report
11%
TCGA Database
11%
Low-grade Tumor
11%
Non-papillary
11%
Papillary Tumor
11%
Overall Survival Progression-free Survival
11%
Metastatic Carcinoma
11%
Metastatic Bladder Cancer
11%
Tumor Histology
11%
Low-grade Urothelial Carcinoma
11%
ANGPT2
11%
ANGPT1
11%
Disease-specific Survival
11%
Pathological Stage
11%
Pharmacology, Toxicology and Pharmaceutical Science
Lipocortin 2
100%
Bladder Cancer
100%
Transitional Cell Carcinoma
100%
Neoplasm
50%
Messenger RNA
50%
Cytokine
25%
Biological Marker
25%
Metastasis
25%
Platelet Derived Growth Factor
25%
Gelatinase B
25%
Overall Survival
25%
Interleukin 6
25%
Plasmin
25%
Progression Free Survival
25%
Papilloma
25%
Disease Specific Survival
25%